This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 May;73(5):939; author reply 939.

doi: 10.1016/j.urology.2008.11.030.

Editorial comment

James E Montie¹

Affiliations

PMID: 19394485
DOI: 10.1016/j.urology.2008.11.030

Comment

Editorial comment

James E Montie. Urology. 2009 May.

. 2009 May;73(5):939; author reply 939.

doi: 10.1016/j.urology.2008.11.030.

Author

James E Montie¹

Affiliation

¹ Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

PMID: 19394485
DOI: 10.1016/j.urology.2008.11.030

No abstract available

PubMed Disclaimer

Comment on

PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.
Kaplan SA, Roehrborn CG, Meehan AG, Liu KS, Carides AD, Binkowitz BS, Heyden NL, Vaughan ED Jr. Kaplan SA, et al. Urology. 2009 May;73(5):935-9. doi: 10.1016/j.urology.2008.09.079. Epub 2009 Mar 28. Urology. 2009. PMID: 19328538 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information